Plain-English translation of NCT06864533 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This trial is testing whether adding chemotherapy after radiation therapy can help men with high-grade prostate cancer have better outcomes. Some men will receive standard radiation therapy alone, while others will receive radiation therapy followed by 4 to 6 rounds of this medication given through an IV. The goal is to see if the added chemotherapy helps prevent the cancer from coming back or spreading.
Aggressive prostate cancer can come back even after standard treatment with radiation or surgery. Researchers want to know if adding this medication after radiation therapy can improve survival and reduce the chances that the cancer will return.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will first receive standard treatment for your prostate cancer, which is either radiation therapy or surgery (or both, depending on your situation). Then, if you are in the chemotherapy group, you will receive 4 to 6 rounds of intravenous chemotherapy starting 4 to 8 weeks after your radiation treatment finishes. Each round of chemotherapy is given 3 weeks apart. Throughout the study, your doctors will monitor you for how well the treatment works and track any side effects, with regular follow-up visits to check your health and cancer status.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
China